Comprehensive Stock Analysis of: Seattle Genetics, Inc. (NASDAQ:SGEN)


Seattle Genetics, Inc. (NASDAQ:SGEN) will report its next earnings on Feb 7 – Feb 13 (Est.). The company reported the earnings of $-0.23/Share in the last quarter where the estimated EPS by analysts was $-0.29/share. The difference between the expected and actual EPS was $0.06/share, which represents an Earnings surprise of 20.7%.

In case of Revenue Estimates, 14 analysts have provided their consensus Average Revenue Estimates for Seattle Genetics, Inc. as 105.45 Million. According to these analysts, the Low Revenue Estimate for Seattle Genetics, Inc. is 93.15 Million and the High Revenue Estimate is 117.4 Million. The company had Year Ago Sales of 93.48 Million.

Some buy side analysts are also providing their Analysis on Seattle Genetics, Inc., where 2 analysts have rated the stock as Strong buy, 6 analysts have given a Buy signal, 8 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. 14 Analysts reported that the Price Target for Seattle Genetics, Inc. might touch $72 high while the Average Price Target and Low price Target is $53.36 and $42 respectively.

To analyze a stock, one should look for Upgrades and Downgrades of a stock. Seattle Genetics, Inc. got Upgrade on 15-Sep-16 where investment firm Goldman Upgrade the stock from Sell to Neutral.

Seattle Genetics, Inc. closed its last trading session at $66.38 with the loss of -2.37%. The Market Capitalization of the company stands at 9.17 Billion. The Company has 52-week high of $75.36 and 52-week low of $26.02. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -2.07% where SMA50 and SMA200 are 10.89% and 45.6% respectively. The Company Touched its 52-Week High on Nov 10, 2016 and 52-Week Low on Feb 10, 2016.

The Relative Volume of the company is 4.95 and Average Volume (3 months) is 1.12 million. Seattle Genetics, Inc. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -12.6%. The Return on Equity (ROE) value stands at -16.3%. While it’s Return on Investment (ROI) value is -17.6%.

While looking at the Stock’s Performance, Seattle Genetics, Inc. currently shows a Weekly Performance of -6.37%, where Monthly Performance is 25.36%, Quarterly performance is 45.48%, 6 Months performance is 48.04% and yearly performance percentage is 55.98%. Year to Date performance value (YTD perf) value is 44.41%. The Stock currently has a Weekly Volatility of 4.43% and Monthly Volatility of 5.81%.